Aging is associated with increased prevalence of axonal injuries characterized by poor regeneration and disability. However, the underlying mechanisms remain unclear. In our experiments, RNA sequencing of sciatic dorsal root ganglia (DRG) revealed significant aging-dependent enrichment in T cell signaling both before and after sciatic nerve injury (SNI) in mice. Lymphotoxin activated the transcription factor NF-κB, which induced expression of the chemokine CXCL13 by neurons. This in turn recruited CXCR5 + CD8 + T cells to injured DRG neurons overexpressing major histocompatibility complex class I. CD8 + T cells repressed the axonal regeneration of DRG neurons via caspase 3 activation. CXCL13 neutralization prevented CXCR5 + CD8 + T cell recruitment to the DRG and reversed aging-dependent regenerative decline, thereby promoting neurological recovery after SNI. Thus, axonal regeneration can be facilitated by antagonizing cross-talk between immune cells and neurons.
Summary: Growing evidence points to a deregulated response to Epstein–Barr virus (EBV) in the central nervous system of patients with multiple sclerosis (MS) as a possible cause of disease. We have investigated the response of a subpopulation of effector CD8+ T cells to EBV in 36 healthy donors and in 35 patients with MS in active and inactive disease. We have measured the expression of markers of degranulation, the release of cytokines, cytotoxicity and the regulation of effector functions by inhibitory receptors, such as programmed death 1 (PD‐1) and human inhibitor receptor immunoglobulin‐like transcript 2 (ILT2). We demonstrate that polyfunctional cytotoxic CD8+ CD57+ T cells are able to kill EBV‐infected cells in healthy donors. In contrast, an anergic exhaustion‐like phenotype of CD8+ CD57+ T cells with high expression of PD‐1 was observed in inactive patients with MS compared with active patients with MS or healthy donors. Detection of CD8+ CD57+ T cells in meningeal inflammatory infiltrates from post‐mortem MS tissue confirmed the association of this cell phenotype with the disease pathological process. The overall results suggest that ineffective immune control of EBV in patietns with MS during remission may be one factor preceding and enabling the reactivation of the virus in the central nervous system and may cause exacerbation of the disease.
Autologous hematopoietic stem cell transplantation (AHSCT) is a therapeutic procedure that has found specific indications in autoimmune disease. The conceptual mechanism of action is that ablation of the lymphoid system followed by immune reconstitution induces a “resetting” of immunological memory. Studies have revealed that the effects of immune reconstitution post-AHSCT include reduced numbers of proinflammatory cells and enhanced regulatory cells, suggesting a rebalancing of the disease-mediating and disease-protective components of disease. Amongst the relevant immune changes, extensive replacement of T cell clones has been demonstrated both in the peripheral blood and in the cerebrospinal fluid of patients with multiple sclerosis.